Biochemistry, Genetics and Molecular Biology
Allele
50%
Allele-Specific Oligonucleotide
5%
Apolipoprotein E
50%
Binding Site
8%
Blood Sampling
5%
Cas9
33%
CD34
25%
Codon
50%
CRISPR/Cas9
25%
Deficiency
50%
Feeder Cell
50%
Gene Flow
25%
Gene Flow
25%
Gene Frequency
54%
Gene Polymorphism
50%
Genetic Susceptibility
16%
Genetics
12%
Genotyping
66%
Globin Gene
8%
Glycoprotein IIb/IIIa
50%
Guide RNA
8%
Hematopoiesis
50%
Hematopoietic Cell
25%
Hemodialysis
100%
Hemoglobin A
5%
Homocysteine
12%
Homozygosity
25%
Homozygote
8%
Human Induced Pluripotent Stem Cell
25%
Induced Pluripotent Stem Cell
41%
Mean Corpuscular Volume
50%
Methylenetetrahydrofolate Reductase
100%
Mutagenesis
25%
NOD2
50%
Nucleobase
16%
Platelet Glycoprotein IIb/IIIa
8%
Point Mutation
25%
Polymerase Chain Reaction
12%
Prevalence
50%
Promoter Region
8%
Protospacer Adjacent Motif
16%
Reprogramming
25%
Restriction Fragment Length Polymorphism
20%
Somatic Cell
20%
Splice Site Mutation
16%
Stem Cell
25%
TLR4
50%
Transposable Element
8%
Neuroscience
5,10 Methylenetetrahydrofolate Reductase (FADH2)
50%
Allele Frequency
56%
Codon
50%
DNA Polymorphism
50%
Enzyme Activity
6%
Fibrinogen Receptor
50%
Hemoglobin A2
50%
Homocysteine
12%
Inflammatory Bowel Disease
50%
Myocardial Infarction
16%
Platelet
8%
Polymerase Chain Reaction
6%
Promoter Region
6%
Restriction Fragment Length Polymorphism
22%
Risk Factor
22%
Somatic Cell
20%
TLR 4
25%
Pharmacology, Toxicology and Pharmaceutical Science
Beta Thalassemia
50%
Binding Site
16%
Combination Therapy
50%
Diseases
66%
End Stage Renal Disease
25%
Fibrinogen Receptor
50%
Heart Infarction
8%
Hemodialysis
25%
Hemoglobin A2
12%
Hemoglobin Beta Chain
16%
Kidney Allograft Rejection
8%
Kidney Disease
8%
Mutagenesis
50%
Nucleic Acid Base
16%
Positive Allosteric Modulator
16%
Prevalence
25%
Thalassemia
50%
